Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benoit H Mulsant

Showing results (391-400 of 607) with videos related to

Pageof 61
Sort By:
Journal of Affective Disorders|July 10, 2002
Course and rate of antidepressant response in the very oldAriel G Gildengers, Patricia R Houck, Benoit H Mulsant, et al.
Journal of Psychiatry & Neuroscience : JPN|January 11, 2020
Magnetic seizure therapy is efficacious and well tolerated for treatment-resistant bipolar depression: an open-label clinical trialVictor M. Tang, Daniel M. Blumberger, Julia Dimitrova, et al.
Journal of Clinical Psychopharmacology|April 25, 2006
What is the optimal duration of a short-term antidepressant trial when treating geriatric depression?Benoit H Mulsant, Patricia R Houck, Ariel G Gildengers, et al.
Psychotherapy and Psychosomatics|September 14, 2017
The Mortality and Myocardial Effects of Antidepressants Are Moderated by Preexisting Cardiovascular Disease: A Meta-AnalysisMarta M Maslej, Benjamin M Bolker, Marley J Russell, et al.
Journal of Affective Disorders|June 7, 2008
Does major depressive disorder with somatic delusions constitute a distinct subtype of major depressive disorder with psychotic features?Taafoi S Kamara, Ellen M Whyte, Benoit H Mulsant, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 28, 2018
Efficacy, tolerability, and cognitive effects of deep transcranial magnetic stimulation for late-life depression: a prospective randomized controlled trialTyler S Kaster, Zafiris J Daskalakis, Yoshihiro Noda, et al.
Epidemiology (Cambridge, Mass.)|December 13, 2012
Economic inequalities in the effectiveness of a primary care intervention for depression and suicidal ideationStephen E Gilman, Garrett M Fitzmaurice, Martha L Bruce, et al.
Journal of the American Geriatrics Society|May 31, 2008
Anticholinergic activity of 107 medications commonly used by older adultsMarci L Chew, Benoit H Mulsant, Bruce G Pollock, et al.
The British Journal of Psychiatry : the Journal of Mental Science|April 3, 2007
Effect of comorbid anxiety on treatment response and relapse risk in late-life depression: controlled studyCarmen Andreescu, Eric J Lenze, Mary Amanda Dew, et al.
Plos One|June 21, 2011
Neurexin-1 and frontal lobe white matter: an overlapping intermediate phenotype for schizophrenia and autism spectrum disordersAristotle N Voineskos, Tristram A P Lett, Jason P Lerch, et al.
Pageof 61

Showing results (391-400 of 607) with videos related to

Sort By:
Pageof 61
Journal of Affective Disorders|July 10, 2002
Course and rate of antidepressant response in the very oldAriel G Gildengers, Patricia R Houck, Benoit H Mulsant, et al.
Journal of Psychiatry & Neuroscience : JPN|January 11, 2020
Magnetic seizure therapy is efficacious and well tolerated for treatment-resistant bipolar depression: an open-label clinical trialVictor M. Tang, Daniel M. Blumberger, Julia Dimitrova, et al.
Journal of Clinical Psychopharmacology|April 25, 2006
What is the optimal duration of a short-term antidepressant trial when treating geriatric depression?Benoit H Mulsant, Patricia R Houck, Ariel G Gildengers, et al.
Psychotherapy and Psychosomatics|September 14, 2017
The Mortality and Myocardial Effects of Antidepressants Are Moderated by Preexisting Cardiovascular Disease: A Meta-AnalysisMarta M Maslej, Benjamin M Bolker, Marley J Russell, et al.
Journal of Affective Disorders|June 7, 2008
Does major depressive disorder with somatic delusions constitute a distinct subtype of major depressive disorder with psychotic features?Taafoi S Kamara, Ellen M Whyte, Benoit H Mulsant, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 28, 2018
Efficacy, tolerability, and cognitive effects of deep transcranial magnetic stimulation for late-life depression: a prospective randomized controlled trialTyler S Kaster, Zafiris J Daskalakis, Yoshihiro Noda, et al.
Epidemiology (Cambridge, Mass.)|December 13, 2012
Economic inequalities in the effectiveness of a primary care intervention for depression and suicidal ideationStephen E Gilman, Garrett M Fitzmaurice, Martha L Bruce, et al.
Journal of the American Geriatrics Society|May 31, 2008
Anticholinergic activity of 107 medications commonly used by older adultsMarci L Chew, Benoit H Mulsant, Bruce G Pollock, et al.
The British Journal of Psychiatry : the Journal of Mental Science|April 3, 2007
Effect of comorbid anxiety on treatment response and relapse risk in late-life depression: controlled studyCarmen Andreescu, Eric J Lenze, Mary Amanda Dew, et al.
Plos One|June 21, 2011
Neurexin-1 and frontal lobe white matter: an overlapping intermediate phenotype for schizophrenia and autism spectrum disordersAristotle N Voineskos, Tristram A P Lett, Jason P Lerch, et al.
Pageof 61